This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 10817536

PUBLISHED SUBJECT

61/8004/2021 - Autorização de Utilização Excecional do Medicamento

WHO CONTRACTED

Parties involved

Place of performance
Portugal, Faro, Faro
NUTS region
PT150 - Algarve

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee
BIOJAM · Tax ID 513642749
Awardee
B. Braun Medical, Unipessoal Lda. · Tax ID 501506543
Awardee
- - RXSOURCE LIMITED
Awardee
BAUSCH LOMB · Tax ID 980218764
Awardee
DUXPHARMA · Tax ID 510803679
Awardee
- - WEP Clinical
Awardee
Goldfarma Produtos Farmacêuticos, Lda · Tax ID 507372328
Awardee
- - CLINIGEN IRELAND LIMITED
Awardee
MEDSZO BV-SUCURSAL EM PORTUGAL · Tax ID 980667917

HOW MUCH AND WHEN

Values and timeline

Contract price
€61,759.61
Procedure base price
€61,759.61
Total effective price
Not reported on Portal BASE
Publication date
12 July 2024
Award date
27 January 2021
Signing date
27 January 2021
Performance period
1 days

The contract price is the value agreed in the contract, not the amount paid.

HOW IT WAS CONTRACTED

Procedure and framework

Contract type
Aquisição de bens móveis
Award criterion
Melhor relação qualidade – preço
CPV code
33690000-3 - Medicamentos vários
Legal basis
Artigo 24.º, n.º 4 do Código dos Contratos Públicos
Regime
Código dos Contratos Públicos ( DL 111-B/2017 )
Framework agreement
Not stated
Centralised procedure
No
Environmental criterion
No
Notice
Not stated
Procedure identifier
7132508

KEEP EXPLORING

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts